Search by Drug Name or NDC
NDC 00054-0319-50 Linezolid 100 mg/5mL Details
Linezolid 100 mg/5mL
Linezolid is a ORAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is LINEZOLID.
MedlinePlus Drug Summary
Linezolid is used to treat infections, including pneumonia, and infections of the skin . Linezolid is in a class of antibacterials called oxazolidinones. It works by stopping the growth of bacteria. Antibiotics such as linezolid will not work for colds, flu, and other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 00054-0319-50Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Linezolid
Product Information
NDC | 00054-0319 |
---|---|
Product ID | 0054-0319_54d662b1-db69-44cd-9bbf-b2d018aa43f6 |
Associated GPIs | 16230040001920 |
GCN Sequence Number | 045132 |
GCN Sequence Number Description | linezolid SUSP RECON 100 MG/5ML ORAL |
HIC3 | W1O |
HIC3 Description | OXAZOLIDINONE ANTIBIOTICS |
GCN | 26871 |
HICL Sequence Number | 021157 |
HICL Sequence Number Description | LINEZOLID |
Brand/Generic | Generic |
Proprietary Name | Linezolid |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | linezolid |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | POWDER, FOR SUSPENSION |
Route | ORAL |
Active Ingredient Strength | 100 |
Active Ingredient Units | mg/5mL |
Substance Name | LINEZOLID |
Labeler Name | Hikma Pharmaceuticals USA Inc. |
Pharmaceutical Class | Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA200068 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00054-0319-50 (00054031950)
NDC Package Code | 0054-0319-50 |
---|---|
Billing NDC | 00054031950 |
Package | 150 mL in 1 BOTTLE (0054-0319-50) |
Marketing Start Date | 2015-06-03 |
NDC Exclude Flag | N |
Pricing Information | N/A |